CoChat

IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms

De Bruyne, Elke, Bos, Tomas J., Schuit, Frans, Van Valckenborgh, Els, Menu, Eline, Thorrez, Lieven, Atadja, Peter, Jernberg-Wiklund, Helena, Vanderkerken, Karin · 2010 · Blood

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Insulin-like growth factor-1 (IGF-1) is an important growth and survival factor in multiple myeloma (MM). Here, we demonstrate that IGF-1 induces significant down-regulation of the proapoptotic BH3-only protein Bim in MM cells. Reduced Bim levels by RNA interference (RNAi) protected cells from drug-induced cell death. The IGF-1–mediated down-regulation of Bim was the result of (1) reduced transcription by activation of the Akt pathway and inactivation of the transcription factor FoxO3a, (2) increased proteasome-mediated degradation of the Bim extra-long protein by activation of the mitogen-activated protein kinase pathway, and (3) epigenetic regulation of both the Bim and the FoxO3a promoter. Treatment of cells with the histone deacetylase inhibitor LBH589 resulted in a clear up-regulation in the expression of Bim. Furthermore, the methylation inhibitor 5-aza-2′deoxycytidine (decitabine) significantly increased the effects of LBH589. On IGF-1 treatment, the Bim promoter region was found to be unmethylated, whereas chromatin immunoprecipitation analysis of the IGF-1–treated cells showed both a reduced histone H3 tail Lys9 (H3K9) acetylation and an increased H3K9 dimethylation, which contributed actively to its silencing. These data identify a new mechanism in the IGF-1–dependent survival of MM cells and emphasize the need for IGF-1–targeted drug therapy.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2009-07-232801

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 58 · Cited by 103

Metadata

Authors
De Bruyne, E., Bos, T. J., Schuit, F., Van Valckenborgh, E., Menu, E., Thorrez, L., Atadja, P., Jernberg-Wiklund, H., & Vanderkerken, K.
Affiliations
  • Department of Hematology and Immunology, Vrije Universiteit Brussel, Brussels, Belgium;
  • Vrije Universiteit Brussel (BE)
  • KU Leuven (BE)
  • Novartis Institute for Biomedical Research Cambridge, Cambridge, MA; and
  • Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
Corresponding author
Bos, Tomas J.
Venue
Blood
Published
2010-03-25
Volume
115
Issue
12
Pages
2430-2440
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2001258425
Cited by
103
References
58
Citations by year
2025: 2 · 2024: 3 · 2023: 11 · 2022: 8 · 2021: 4 · 2020: 5 · 2019: 6 · 2018: 7 · 2017: 9 · 2016: 4 · 2015: 5 · 2014: 8 · 2013: 8 · 2012: 14
FWCI
6.21
Type
journal article
Language
en
Update notices
erratum (2023-09-14)
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
  • VUBIR (Vrije Universiteit Brussel) (submittedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Keywords
insulin-like growth factor I, multiple myeloma, building information modeling, apoptosis, FOXO3, Akt signaling, proteasomal degradation, MAPK signaling, epigenetic regulation, DNA methylation, histone H3K9 acetylation, histone deacetylase inhibitors, panobinostat, decitabine, cell survival
MeSH terms
Forkhead Box Protein O3, Bcl-2-Like Protein 11, Panobinostat, Animals, Cell Survival, Histones, Humans, Hydroxamic Acids, Immunoglobulin G, Indoles, Insulin-Like Growth Factor I, Kidney, Melphalan, Membrane Proteins, Mice, Inbred C57BL, Multiple Myeloma, Protein Processing, Post-Translational, Proto-Oncogene Proteins, Down-Regulation, Gene Expression Regulation, Neoplastic, Apoptosis, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinase 1, Gene Silencing, Gene Expression Profiling, Epigenesis, Genetic, Cell Line, Tumor, Mitogen-Activated Protein Kinase 3, Apoptosis Regulatory Proteins, Mice, Forkhead Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms. https://app.cochat.ai/papers/10.1182/blood-2009-07-232801
The paper
De Bruyne, E., Bos, T. J., Schuit, F., Van Valckenborgh, E., Menu, E., Thorrez, L., Atadja, P., Jernberg-Wiklund, H., & Vanderkerken, K. (2010). IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms. Blood. https://doi.org/10.1182/blood-2009-07-232801

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.